{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:55:41Z","timestamp":1787003741605,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-81795-z","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T12:29:28Z","timestamp":1733142568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of body mass index on the efficacy of treatment modalities in women with refractory overactive bladder"],"prefix":"10.1038","volume":"14","author":[{"given":"Po-En","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiun-Chyi","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Hsien","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Hsuan","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"key":"81795_CR1","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","volume":"50","author":"DE Irwin","year":"2006","unstructured":"Irwin, D. E. et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur. Urol. 50, 1306\u20131314 (2006).","journal-title":"Eur. Urol."},{"key":"81795_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejogrb.2024.02.010","volume":"295","author":"B Alsannan","year":"2024","unstructured":"Alsannan, B. et al. Prevalence of overactive bladder among overweight and obese women: a prospective cross-sectional cohort study. Eur. J. Obstet. Gynecol. Reprod. Biol. 295, 59\u201364 (2024).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"81795_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejogrb.2015.11.018","volume":"196","author":"J Krhut","year":"2016","unstructured":"Krhut, J. et al. Impact of body mass index on treatment efficacy of mirabegron for overactive bladder in females. Eur. J. Obstet. Gynecol. Reprod. Biol. 196, 64\u201368 (2016).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"81795_CR4","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.eururo.2014.02.012","volume":"67","author":"P Abrams","year":"2015","unstructured":"Abrams, P. et al. Combination treatment with mirabegron and solifenacin in patients with overactive bladder: efficacy and safety results from a randomised double-blind dose-ranging phase 2 study (Symphony). Eur. Urol. 67, 577\u2013588 (2015).","journal-title":"Eur. Urol."},{"key":"81795_CR5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.eururo.2019.07.010","volume":"76","author":"C Gratzke","year":"2019","unstructured":"Gratzke, C. et al. Efficacy and safety of Combination Pharmacotherapy for patients with overactive bladder: a Rapid evidence Assessment. Eur. Urol.. Eur. Urol. 76, 767\u2013779 (2019).","journal-title":"Eur. Urol."},{"key":"81795_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.eururo.2013.04.001","volume":"64","author":"C Chapple","year":"2013","unstructured":"Chapple, C. et al. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial. Eur. Urol. 64, 249\u2013256 (2013).","journal-title":"Eur. Urol."},{"key":"81795_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/nau.1930140206","volume":"14","author":"JS Uebersax","year":"1995","unstructured":"Uebersax, J. S., Wyman, J. F., Shumaker, S. A., McClish, D. K. & Fantl, J. A. Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the urogenital distress inventory. Neurourol. Urodyn. 14, 131\u2013139 (1995).","journal-title":"Neurourol. Urodyn."},{"key":"81795_CR8","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.urology.2006.02.042","volume":"68","author":"Y Homma","year":"2006","unstructured":"Homma, Y. et al. Symptom assessment tool for overactive bladder syndrome\u2013overactive bladder symptom score. Urology 68, 318\u2013323 (2006).","journal-title":"Urology"},{"key":"81795_CR9","doi-asserted-by":"publisher","first-page":"e0274134","DOI":"10.1371\/journal.pone.0274134","volume":"17","author":"TJ Wong","year":"2022","unstructured":"Wong, T. J. & Yu, T. Trends in the distribution of body mass index, waist circumference, and prevalence of obesity among Taiwanese adults, 1993\u20132016. PLoS One. 17, e0274134 (2022).","journal-title":"PLoS One"},{"key":"81795_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.5213\/inj.2012.16.3.126","volume":"16","author":"TF Al-Shaiji","year":"2012","unstructured":"Al-Shaiji, T. F. & Radomski, S. B. Relationship between body mass index and overactive bladder in women and correlations with urodynamic evaluation. Int. Neurourol. J. 16, 126\u2013131 (2012).","journal-title":"Int. Neurourol. J."},{"key":"81795_CR11","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.eururo.2019.02.038","volume":"75","author":"B Peyronnet","year":"2019","unstructured":"Peyronnet, B. et al. A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment. Eur. Urol. 75, 988\u20131000 (2019).","journal-title":"Eur. Urol."},{"key":"81795_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.urology.2020.04.115","volume":"143","author":"MA Elbaset","year":"2020","unstructured":"Elbaset, M. A., Taha, D. E., Sharaf, D. E., Ashour, R. & El-Hefnawy, A. S. Obesity and overactive bladder: is it a matter of body weight, fat distribution, or function? A preliminary results. Urology 143, 91\u201396 (2020).","journal-title":"Urology"},{"key":"81795_CR13","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1007\/s11255-014-0832-9","volume":"46","author":"M Dursun","year":"2014","unstructured":"Dursun, M. et al. Stress urinary incontinence and visceral adipose index: a new risk parameter. Int. Urol. Nephrol. 46, 2297\u20132303 (2014).","journal-title":"Int. Urol. Nephrol."},{"key":"81795_CR14","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1007\/s00384-021-03968-w","volume":"36","author":"CR Rowan","year":"2021","unstructured":"13, Rowan, C. R., McManus, J., Boland, K. & O\u2019Toole, A. Visceral adiposity and inflammatory bowel disease. Int. J. Colorectal Dis. 36, 2305\u20132319 (2021).","journal-title":"Int. J. Colorectal Dis."},{"key":"81795_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/nau.20583","volume":"28","author":"LH Tseng","year":"2009","unstructured":"Tseng, L. H. et al. Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome. Neurourol. Urodyn. 28, 47\u201351 (2009).","journal-title":"Neurourol. Urodyn."},{"key":"81795_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/luts.12262","volume":"11","author":"LC Chen","year":"2019","unstructured":"Chen, L. C. & Kuo, H. C. Pathophysiology of refractory overactive bladder. Low Urin Tract. Symptoms. 11, 177\u2013181 (2019).","journal-title":"Low Urin Tract. Symptoms"},{"key":"81795_CR17","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1056\/NEJMoa1208872","volume":"367","author":"AG Visco","year":"2012","unstructured":"Visco, A. G. et al. Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. N. Engl. J. Med. 367, 1803\u20131813 (2012).","journal-title":"N. Engl. J. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81795-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81795-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81795-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T13:04:16Z","timestamp":1733144656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81795-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["81795"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-81795-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4929290\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,2]]},"assertion":[{"value":"17 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29990"}}